• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Ligand Pharmaceuticals Incorporated - Common Stock (NQ:LGND)

    256.12 +0.58 (+0.23%)
    Streaming Delayed Price Updated: 11:45 AM EDT, Jun 15, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 30,164
    Open 254.26
    Bid (Size) 255.47 (100)
    Ask (Size) 258.68 (100)
    Prev. Close 255.54
    Today's Range 253.35 - 257.32
    52wk Range 110.00 - 259.03
    Shares Outstanding 16,676,532
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Ligand Pharmaceuticals Director Unloads 2,501 Shares — Should You Be Concerned? ↗
    This biotech innovator, known for its royalty-driven model, reported a notable insider sale amid a period of strong share price gains. 
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    A Ligand Pharmaceuticals (LGND) Insider Sold 5,000 Shares for $1.1 Million ↗
    Biotech royalty player Ligand Pharmaceuticals reported a notable insider sale following a year of strong stock performance. 
    Via The Motley Fool
    Topics Regulatory Compliance

    Performance

    YTD
    +34.7%
    +34.7%
    1 Month
    +20.1%
    +20.1%
    3 Month
    +23.3%
    +23.3%
    6 Month
    +32.8%
    +32.8%
    1 Year
    +122.7%
    +122.7%

    More News

    Read More
    News headline image
    Wealth Manager Sells $7 Million of Establishment Labs After Massive Gains. Is This Medical Device Stock a Buy? ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    Ligand Pharmaceuticals (NASDAQ:LGND) Shares Fall on Q1 Revenue and EPS Miss ↗
    Via Chartmill
    Ligand Pharmaceuticals (NASDAQ:LGND) Passes Minervini Trend Template and Growth Screen ↗
    Via Chartmill
    Ligand Pharmaceuticals (NASDAQ:LGND) Beats Q4 Estimates and Reaffirms 2026 Guidance ↗
    Via Chartmill
    News headline image
    OneSpaWorld Posted Record Revenue for Last Quarter. Why Did a Fund Exit a $21.5 Million Stake? ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Is Genpact Stock a Buy After Hedge Fund Rice Hall James Raised Its Stake by $14 Million? ↗
    Via The Motley Fool
    Topics Artificial Intelligence Economy
    News headline image
    Is WaterBridge Stock a Buy After Ranger Investment Raised Its Stake by 345,000 Shares? ↗
    Via The Motley Fool
    Topics Initial Public Offering
    News headline image
    Orchestra BioMed Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    News headline image
    Ligand (LGND) Q1 2026 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Ligand Pharmaceuticals Q1 Earnings Call Highlights ↗
    Via MarketBeat
    Topics Earnings
    News headline image
    Orchestra BioMed Receives $15 Million Investment from Ligand Under Previously Announced Strategic Financing Agreement
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    News headline image
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: XOMA Royalty Corporation (Nasdaq – XOMA), Organon & Co. (NYSE – OGN), RE/MAX Holdings, Inc. (NYSE – RMAX), Soleno Therapeutics, Inc. (Nasdaq – SLNO)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    News headline image
    Villere St Denis Liquidates $18 Million Euronet Worldwide Stake, According to Recent SEC Filing ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Villere St Denis Dumps 134,000 Tidewater (TDW) Shares Worth $9.3 Million ↗
    Via The Motley Fool
    Topics Energy Regulatory Compliance
    News headline image
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: XOMA Royalty Corporation (Nasdaq – XOMA), Organon & Co. (NYSE – OGN), RE/MAX Holdings, Inc. (NYSE – RMAX), Soleno Therapeutics, Inc. (Nasdaq – SLNO)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    News headline image
    Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator
    From XOMA Royalty Corporation
    Via GlobeNewswire
    News headline image
    CLO Sells LGND 5,000 Shares for $1.0 Million ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Ligand Pharma CFO Sells $688K in Stock as Shares Surge 80% This Past Year. Here's What to Know ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Rice Hall James Buys QuidelOrtho Stock ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Rice Hall James Buys Stride Stock ↗
    Via The Motley Fool
    News headline image
    Ligand Pharma (LGND) Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    The Great Rotation: Small-Caps Break the Mega-Cap Monopoly in Early 2026
    Via MarketMinute
    Topics Artificial Intelligence Earnings Economy
    News headline image
    This $38.8 Million Vicor Bet Is Getting Bigger Amid a 200% Stock Surge ↗
    Via The Motley Fool

    Frequently Asked Questions

    Is Ligand Pharmaceuticals Incorporated - Common Stock publicly traded?
    Yes, Ligand Pharmaceuticals Incorporated - Common Stock is publicly traded.
    What exchange does Ligand Pharmaceuticals Incorporated - Common Stock trade on?
    Ligand Pharmaceuticals Incorporated - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Ligand Pharmaceuticals Incorporated - Common Stock?
    The ticker symbol for Ligand Pharmaceuticals Incorporated - Common Stock is LGND on the Nasdaq Stock Market
    What is the current price of Ligand Pharmaceuticals Incorporated - Common Stock?
    The current price of Ligand Pharmaceuticals Incorporated - Common Stock is 256.12
    When was Ligand Pharmaceuticals Incorporated - Common Stock last traded?
    The last trade of Ligand Pharmaceuticals Incorporated - Common Stock was at 06/15/26 11:45 AM ET
    What is the market capitalization of Ligand Pharmaceuticals Incorporated - Common Stock?
    The market capitalization of Ligand Pharmaceuticals Incorporated - Common Stock is 4.27B
    How many shares of Ligand Pharmaceuticals Incorporated - Common Stock are outstanding?
    Ligand Pharmaceuticals Incorporated - Common Stock has 4B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.